APA (7th ed.) Citation

Silverberg, J. I., Irvine, A. D., Foley, P., Del Rosso, J., Puig, L., Stein Gold, L., . . . Chovatiya, R. (2026). A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence. Dermatology & Therapy, 1. https://doi.org/10.1007/s13555-026-01791-1

Chicago Style (17th ed.) Citation

Silverberg, Jonathan I., et al. "A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence." Dermatology & Therapy 2026: 1. https://doi.org/10.1007/s13555-026-01791-1.

MLA (9th ed.) Citation

Silverberg, Jonathan I., et al. "A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence." Dermatology & Therapy, 2026, p. 1, https://doi.org/10.1007/s13555-026-01791-1.